Loading…

Colorectal cancer after a negative Haemoccult II test and programme sensitivity after a first round of screening: The experience of the Department of Calvados (France)

Summary Colorectal cancers emerging after a negative Haemoccult II ® are described in the context of a first round of mass screening in the Department of Calvados (France), from April 1991 to the end of December 1994. People with a cancer occurring after a negative test until 31 December 1995 were i...

Full description

Saved in:
Bibliographic Details
Published in:British Journal of Cancer 1999-09, Vol.81 (2), p.305-309
Main Authors: Bouvier, V, Launoy, G, Herbert, C, Lefevre, H, Maurel, J, Gignoux, M
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c477t-382242d9f006e917999f53ebe55ebf9278c30261b9567f524ab8e1b7d3657fe23
cites cdi_FETCH-LOGICAL-c477t-382242d9f006e917999f53ebe55ebf9278c30261b9567f524ab8e1b7d3657fe23
container_end_page 309
container_issue 2
container_start_page 305
container_title British Journal of Cancer
container_volume 81
creator Bouvier, V
Launoy, G
Herbert, C
Lefevre, H
Maurel, J
Gignoux, M
description Summary Colorectal cancers emerging after a negative Haemoccult II ® are described in the context of a first round of mass screening in the Department of Calvados (France), from April 1991 to the end of December 1994. People with a cancer occurring after a negative test until 31 December 1995 were identified by a local cancer registry. Incidence was calculated and the programme sensitivity was estimated. The incidence of cancer emerging after a negative test was 57.7 per 100 000, i.e. half of the calculated incidence in the reference group (141.6 per 100 000). These cancers did not differ from those of either the non-responder or reference groups, in particular for the stage of extension. The programme sensitivity was globally higher than that estimated in European trials: 77.2, 66.3 and 55.9%, 1, 2 and 3 years after the test respectively. Programme sensitivity was higher for distal colon cancer 1 year after the test, which is probably due to the relatively slow growth of this subsite.
doi_str_mv 10.1038/sj.bjc.6990692
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2362867</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70049004</sourcerecordid><originalsourceid>FETCH-LOGICAL-c477t-382242d9f006e917999f53ebe55ebf9278c30261b9567f524ab8e1b7d3657fe23</originalsourceid><addsrcrecordid>eNp1ksFu1DAQhiMEokvhyg3kA6rgsFvH2dhxD0jVQulKlbiUs-U449RRYgfbWdEn4jVxlNVSDhxsS_6_-Wc84yx7m-NNjovqMnSbulMbyjmmnDzLVvmW0XVZVPnzbIUxZmvMCT7LXoXQYZxEVr7MznK85bQo2Sr7vXO986Ci7JGSVoFHUsd5RxZaGc0B0K2EwSk19RHt9yhCiEjaBo3etV4OA6AANpiEmvh4itbGJ867KZFOo6A8gDW2vUL3D4Dg1wjeQMo3izHdfIFR-jiAjfPNTvYH2biAPt74uapPr7MXWvYB3hzP8-zHzdf73e367vu3_e76bq3S0-K6qAjZkoZrjCnwnHHOdVlADWUJteaEVarAhOY1LynTJdnKuoK8Zk1BS6aBFOfZ58V3nOoBGpXq8bIXozeD9I_CSSP-Vax5EK07CFJQUlGWDC6OBt79nFKvxGCCgr6XFtwUBMOp92klcLOAyrsQPOhTkhyLebYidCLNVhxnmwLePy3tCb4MMwEfjoAMSvZ67pwJf7n0EQiZfS4XLCTFtuBF5yZvU1f_n_ndEmFlnDycHCld9D9zdcot</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70049004</pqid></control><display><type>article</type><title>Colorectal cancer after a negative Haemoccult II test and programme sensitivity after a first round of screening: The experience of the Department of Calvados (France)</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><source>PubMed Central</source><creator>Bouvier, V ; Launoy, G ; Herbert, C ; Lefevre, H ; Maurel, J ; Gignoux, M</creator><creatorcontrib>Bouvier, V ; Launoy, G ; Herbert, C ; Lefevre, H ; Maurel, J ; Gignoux, M</creatorcontrib><description>Summary Colorectal cancers emerging after a negative Haemoccult II ® are described in the context of a first round of mass screening in the Department of Calvados (France), from April 1991 to the end of December 1994. People with a cancer occurring after a negative test until 31 December 1995 were identified by a local cancer registry. Incidence was calculated and the programme sensitivity was estimated. The incidence of cancer emerging after a negative test was 57.7 per 100 000, i.e. half of the calculated incidence in the reference group (141.6 per 100 000). These cancers did not differ from those of either the non-responder or reference groups, in particular for the stage of extension. The programme sensitivity was globally higher than that estimated in European trials: 77.2, 66.3 and 55.9%, 1, 2 and 3 years after the test respectively. Programme sensitivity was higher for distal colon cancer 1 year after the test, which is probably due to the relatively slow growth of this subsite.</description><identifier>ISSN: 0007-0920</identifier><identifier>EISSN: 1476-5381</identifier><identifier>EISSN: 1532-1827</identifier><identifier>DOI: 10.1038/sj.bjc.6990692</identifier><identifier>PMID: 10496357</identifier><identifier>CODEN: BJCAAI</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>Aged ; Biological and medical sciences ; Biomedical and Life Sciences ; Biomedicine ; Cancer Research ; Colorectal Neoplasms - prevention &amp; control ; Drug Resistance ; Epidemiology ; Female ; France ; Gastroenterology. Liver. Pancreas. Abdomen ; Humans ; Male ; Mass Screening ; Medical sciences ; Middle Aged ; Molecular Medicine ; Occult Blood ; Oncology ; Regular ; regular-article ; Sensitivity and Specificity ; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus ; Tumors</subject><ispartof>British Journal of Cancer, 1999-09, Vol.81 (2), p.305-309</ispartof><rights>The Author(s) 1999</rights><rights>1999 INIST-CNRS</rights><rights>Copyright © 1999 Cancer Research Campaign 1999 Cancer Research Campaign</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c477t-382242d9f006e917999f53ebe55ebf9278c30261b9567f524ab8e1b7d3657fe23</citedby><cites>FETCH-LOGICAL-c477t-382242d9f006e917999f53ebe55ebf9278c30261b9567f524ab8e1b7d3657fe23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362867/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362867/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1920222$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10496357$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bouvier, V</creatorcontrib><creatorcontrib>Launoy, G</creatorcontrib><creatorcontrib>Herbert, C</creatorcontrib><creatorcontrib>Lefevre, H</creatorcontrib><creatorcontrib>Maurel, J</creatorcontrib><creatorcontrib>Gignoux, M</creatorcontrib><title>Colorectal cancer after a negative Haemoccult II test and programme sensitivity after a first round of screening: The experience of the Department of Calvados (France)</title><title>British Journal of Cancer</title><addtitle>Br J Cancer</addtitle><addtitle>Br J Cancer</addtitle><description>Summary Colorectal cancers emerging after a negative Haemoccult II ® are described in the context of a first round of mass screening in the Department of Calvados (France), from April 1991 to the end of December 1994. People with a cancer occurring after a negative test until 31 December 1995 were identified by a local cancer registry. Incidence was calculated and the programme sensitivity was estimated. The incidence of cancer emerging after a negative test was 57.7 per 100 000, i.e. half of the calculated incidence in the reference group (141.6 per 100 000). These cancers did not differ from those of either the non-responder or reference groups, in particular for the stage of extension. The programme sensitivity was globally higher than that estimated in European trials: 77.2, 66.3 and 55.9%, 1, 2 and 3 years after the test respectively. Programme sensitivity was higher for distal colon cancer 1 year after the test, which is probably due to the relatively slow growth of this subsite.</description><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cancer Research</subject><subject>Colorectal Neoplasms - prevention &amp; control</subject><subject>Drug Resistance</subject><subject>Epidemiology</subject><subject>Female</subject><subject>France</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Humans</subject><subject>Male</subject><subject>Mass Screening</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Molecular Medicine</subject><subject>Occult Blood</subject><subject>Oncology</subject><subject>Regular</subject><subject>regular-article</subject><subject>Sensitivity and Specificity</subject><subject>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</subject><subject>Tumors</subject><issn>0007-0920</issn><issn>1476-5381</issn><issn>1532-1827</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNp1ksFu1DAQhiMEokvhyg3kA6rgsFvH2dhxD0jVQulKlbiUs-U449RRYgfbWdEn4jVxlNVSDhxsS_6_-Wc84yx7m-NNjovqMnSbulMbyjmmnDzLVvmW0XVZVPnzbIUxZmvMCT7LXoXQYZxEVr7MznK85bQo2Sr7vXO986Ci7JGSVoFHUsd5RxZaGc0B0K2EwSk19RHt9yhCiEjaBo3etV4OA6AANpiEmvh4itbGJ867KZFOo6A8gDW2vUL3D4Dg1wjeQMo3izHdfIFR-jiAjfPNTvYH2biAPt74uapPr7MXWvYB3hzP8-zHzdf73e367vu3_e76bq3S0-K6qAjZkoZrjCnwnHHOdVlADWUJteaEVarAhOY1LynTJdnKuoK8Zk1BS6aBFOfZ58V3nOoBGpXq8bIXozeD9I_CSSP-Vax5EK07CFJQUlGWDC6OBt79nFKvxGCCgr6XFtwUBMOp92klcLOAyrsQPOhTkhyLebYidCLNVhxnmwLePy3tCb4MMwEfjoAMSvZ67pwJf7n0EQiZfS4XLCTFtuBF5yZvU1f_n_ndEmFlnDycHCld9D9zdcot</recordid><startdate>19990901</startdate><enddate>19990901</enddate><creator>Bouvier, V</creator><creator>Launoy, G</creator><creator>Herbert, C</creator><creator>Lefevre, H</creator><creator>Maurel, J</creator><creator>Gignoux, M</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19990901</creationdate><title>Colorectal cancer after a negative Haemoccult II test and programme sensitivity after a first round of screening: The experience of the Department of Calvados (France)</title><author>Bouvier, V ; Launoy, G ; Herbert, C ; Lefevre, H ; Maurel, J ; Gignoux, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c477t-382242d9f006e917999f53ebe55ebf9278c30261b9567f524ab8e1b7d3657fe23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cancer Research</topic><topic>Colorectal Neoplasms - prevention &amp; control</topic><topic>Drug Resistance</topic><topic>Epidemiology</topic><topic>Female</topic><topic>France</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Humans</topic><topic>Male</topic><topic>Mass Screening</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Molecular Medicine</topic><topic>Occult Blood</topic><topic>Oncology</topic><topic>Regular</topic><topic>regular-article</topic><topic>Sensitivity and Specificity</topic><topic>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bouvier, V</creatorcontrib><creatorcontrib>Launoy, G</creatorcontrib><creatorcontrib>Herbert, C</creatorcontrib><creatorcontrib>Lefevre, H</creatorcontrib><creatorcontrib>Maurel, J</creatorcontrib><creatorcontrib>Gignoux, M</creatorcontrib><collection>SpringerOpen</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British Journal of Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bouvier, V</au><au>Launoy, G</au><au>Herbert, C</au><au>Lefevre, H</au><au>Maurel, J</au><au>Gignoux, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Colorectal cancer after a negative Haemoccult II test and programme sensitivity after a first round of screening: The experience of the Department of Calvados (France)</atitle><jtitle>British Journal of Cancer</jtitle><stitle>Br J Cancer</stitle><addtitle>Br J Cancer</addtitle><date>1999-09-01</date><risdate>1999</risdate><volume>81</volume><issue>2</issue><spage>305</spage><epage>309</epage><pages>305-309</pages><issn>0007-0920</issn><eissn>1476-5381</eissn><eissn>1532-1827</eissn><coden>BJCAAI</coden><abstract>Summary Colorectal cancers emerging after a negative Haemoccult II ® are described in the context of a first round of mass screening in the Department of Calvados (France), from April 1991 to the end of December 1994. People with a cancer occurring after a negative test until 31 December 1995 were identified by a local cancer registry. Incidence was calculated and the programme sensitivity was estimated. The incidence of cancer emerging after a negative test was 57.7 per 100 000, i.e. half of the calculated incidence in the reference group (141.6 per 100 000). These cancers did not differ from those of either the non-responder or reference groups, in particular for the stage of extension. The programme sensitivity was globally higher than that estimated in European trials: 77.2, 66.3 and 55.9%, 1, 2 and 3 years after the test respectively. Programme sensitivity was higher for distal colon cancer 1 year after the test, which is probably due to the relatively slow growth of this subsite.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>10496357</pmid><doi>10.1038/sj.bjc.6990692</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-0920
ispartof British Journal of Cancer, 1999-09, Vol.81 (2), p.305-309
issn 0007-0920
1476-5381
1532-1827
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2362867
source Wiley-Blackwell Read & Publish Collection; PubMed Central
subjects Aged
Biological and medical sciences
Biomedical and Life Sciences
Biomedicine
Cancer Research
Colorectal Neoplasms - prevention & control
Drug Resistance
Epidemiology
Female
France
Gastroenterology. Liver. Pancreas. Abdomen
Humans
Male
Mass Screening
Medical sciences
Middle Aged
Molecular Medicine
Occult Blood
Oncology
Regular
regular-article
Sensitivity and Specificity
Stomach. Duodenum. Small intestine. Colon. Rectum. Anus
Tumors
title Colorectal cancer after a negative Haemoccult II test and programme sensitivity after a first round of screening: The experience of the Department of Calvados (France)
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T14%3A32%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Colorectal%20cancer%20after%20a%20negative%20Haemoccult%20II%20test%20and%20programme%20sensitivity%20after%20a%20first%20round%20of%20screening:%20The%20experience%20of%20the%20Department%20of%20Calvados%20(France)&rft.jtitle=British%20Journal%20of%20Cancer&rft.au=Bouvier,%20V&rft.date=1999-09-01&rft.volume=81&rft.issue=2&rft.spage=305&rft.epage=309&rft.pages=305-309&rft.issn=0007-0920&rft.eissn=1476-5381&rft.coden=BJCAAI&rft_id=info:doi/10.1038/sj.bjc.6990692&rft_dat=%3Cproquest_pubme%3E70049004%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c477t-382242d9f006e917999f53ebe55ebf9278c30261b9567f524ab8e1b7d3657fe23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=70049004&rft_id=info:pmid/10496357&rfr_iscdi=true